P230025 Safety Effectiveness Data Summary

FDA published a Final Order for Premarket Approval (PMA) application P230025, documenting the agency's review and approval determination for a medical device. The order summarizes the safety and effectiveness data relied upon by FDA in making its approval decision, including clinical study results and bench testing outcomes.\n\nMedical device manufacturers pursuing PMA approval should ensure their applications include comprehensive safety and effectiveness data packages, as FDA's final orders reflect the agency's scientific evaluation standards for market authorization. Sponsors with pending PMA applications should monitor FDA's documentation approach demonstrated in this order for alignment with regulatory expectations.